|
1
|
Rose CF, Amodio P, Bajaj JS, Dhiman RK,
Montagnese S, Taylor-Robinson SD, Vilstrup H and Jalan R: Hepatic
encephalopathy: Novel insights into classification, pathophysiology
and therapy. J Hepatol. 73:1526–1547. 2020.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Hirode G, Vittinghoff E and Wong RJ:
Increasing burden of hepatic encephalopathy among hospitalized
adults: An analysis of the 2010-2014 National Inpatient Sample. Dig
Dis Sci. 64:1448–1457. 2019.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Felipo V: Hepatic encephalopathy: Effects
of liver failure on brain function. Nat Rev Neurosci. 14:851–858.
2013.PubMed/NCBI View
Article : Google Scholar
|
|
4
|
Poh Z and Chang PE: A current review of
the diagnostic and treatment strategies of hepatic encephalopathy.
Int J Hepatol. 2012(480309)2012.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Riggio O, Nardelli S, Moscucci F, Pasquale
C, Ridola L and Merli M: Hepatic encephalopathy after transjugular
intrahepatic portosystemic shunt. Clin Liver Dis. 16:133–146.
2012.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Pereira K, Carrion AF, Martin P, Vaheesan
K, Salsamendi J, Doshi M and Yrizarry JM: Current diagnosis and
management of post-transjugular intrahepatic portosystemic shunt
refractory hepatic encephalopathy. Liver Int. 35:2487–2494.
2015.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Romero-Gomez M, Jover M, Diaz-Gomez D, de
Teran LC, Rodrigo R, Camacho I, Echevarria M, Felipo V and Bautista
JD: Phosphate-activated glutaminase activity is enhanced in brain,
intestine and kidneys of rats following portacaval anastomosis.
World J Gastroenterol. 12:2406–2411. 2006.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Perarnau JM, Le Gouge A, Nicolas C,
d'Alteroche L, Borentain P, Saliba F, Minello A, Anty R,
Chagneau-Derrode C, Bernard PH, et al: Covered vs. uncovered stents
for transjugular intrahepatic portosystemic shunt: A randomized
controlled trial. J Hepatol. 60:962–968. 2014.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Bureau C, Garcia-Pagan JC, Otal P,
Pomier-Layrargues G, Chabbert V, Cortez C, Perreault P, Péron JM,
Abraldes JG, Bouchard L, et al: Improved clinical outcome using
polytetrafluoroethylene-coated stents for TIPS: Results of a
randomized study. Gastroenterology. 126:469–475. 2004.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Riggio O, Angeloni S and Ridola L: Hepatic
encephalopathy after transjugular intrahepatic portosystemic shunt:
Still a major problem. Hepatology. 51:2237–2238. 2010.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Laleman W, Simon-Talero M, Maleux G, Perez
M, Ameloot K, Soriano G, Villalba J, Garcia-Pagan JC, Barrufet M,
Jalan R, et al: Embolization of large spontaneous portosystemic
shunts for refractory hepatic encephalopathy: A multicenter survey
on safety and efficacy. Hepatology. 57:2448–2457. 2013.PubMed/NCBI View Article : Google Scholar
|
|
12
|
An J, Kim KW, Han S, Lee J and Lim YS:
Improvement in survival associated with embolisation of spontaneous
portosystemic shunt in patients with recurrent hepatic
encephalopathy. Aliment Pharmacol Ther. 39:1418–1426.
2014.PubMed/NCBI View Article : Google Scholar
|
|
13
|
He C, Lv Y, Wang Z, Guo W, Tie J, Li K,
Niu J, Zuo L, Yu T, Yuan X, et al: Association between non-variceal
spontaneous portosystemic shunt and outcomes after TIPS in
cirrhosis. Dig Liver Dis. 50:1315–1323. 2018.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Lv Y, Chen H, Luo B, Bai W, Li K, Wang Z,
Xia D, Guo W, Wang Q, Li X, et al: Concurrent large spontaneous
portosystemic shunt embolization for the prevention of overt
hepatic encephalopathy after TIPS: A randomized controlled trial.
Hepatology. 76:676–688. 2022.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Moher D, Liberati A, Tetzlaff J and Altman
DG: PRISMA Group. Preferred reporting items for systematic reviews
and meta-analyses: The PRISMA statement. PLoS Med.
6(e1000097)2009.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Vilstrup H, Amodio P, Bajaj J, Cordoba J,
Ferenci P, Mullen KD, Weissenborn K and Wong P: Hepatic
encephalopathy in chronic liver disease: 2014 practice guideline by
the American association for the study of liver diseases and the
European association for the study of the liver. Hepatology.
60:715–735. 2014.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Higgins JPT, Thomas J, Chandler J,
Cumpston M, Li T, Page MJ and Welch VA: Cochrane handbook for
systematic reviews of interventions. 2nd edition. John Wiley &
Sons, Chichester, 2019.
|
|
18
|
Luo C, Marks-Anglin A, Duan R, Lin L, Hong
C, Chu H and Chen Y: Accounting for publication bias using a
bivariate trim and fill meta-analysis procedure. Stat Med.
41:3466–3478. 2022.PubMed/NCBI View
Article : Google Scholar
|
|
19
|
Greenhouse JB and Iyengar S: Sensitivity
analysis and diagnostics. In: The handbook of research synthesis
and meta-analysis. Cooper H, Hedges LV and Valentine JC (eds). 2nd
edition. Russell Sage Foundation, pp 417-433, 2009.
|
|
20
|
Philips CA, Kumar L and Augustine P: Shunt
occlusion for portosystemic shunt syndrome related refractory
hepatic encephalopathy-A single-center experience in 21 patients
from Kerala. Indian J Gastroenterol. 36:411–419. 2017.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Zhang L, Wei B, Wang Z, Tong H and Wu H:
Treatment of refractory hepatic encephalopathy induced by
spontaneous portosystemic shunt: Selective splenic vein
embolization versus shunt embolization. Dig Liver Dis. 55:381–386.
2023.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Ke Q, He J, Cai L, Lei X, Huang X, Li L,
Liu J and Guo W: Safety and efficacy of interventional embolization
in cirrhotic patients with refractory hepatic encephalopathy
associated with spontaneous portosystemic shunts. Sci Rep.
14(14848)2024.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Higgins JP and Green S: Cochrane handbook
for systematic reviews of interventions. The Cochrane
Collaboration, 2008.
|
|
24
|
Philips CA, Rajesh S, Augustine P,
Padsalgi G and Ahamed R: Portosystemic shunts and refractory
hepatic encephalopathy: Patient selection and current options.
Hepat Med. 11:23–34. 2019.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Simón-Talero M, Roccarina D, Martínez J,
Lampichler K, Baiges A, Low G, Llop E, Praktiknjo M, Maurer MH,
Zipprich A, et al: Association between portosystemic shunts and
increased complications and mortality in patients with cirrhosis.
Gastroenterology. 154:1694–1705.e4. 2018.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Chikamori F, Kuniyoshi N, Shibuya S and
Takase Y: Transjugular retrograde obliteration for chronic
portosystemic encephalopathy. Abdom Imaging. 25:567–571.
2000.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Cardoso JE, Gautreau C, Jeyaraj PR,
Patrzalek D, Cherruau B, Vaubourdolle M, Legendre C, Wroblewski T
and Houssin D: Augmentation of portal blood flow improves function
of human cirrhotic liver. Hepatology. 19:375–380. 1994.PubMed/NCBI
|
|
28
|
Sakurabayashi S, Sezai S, Yamamoto Y,
Hirano M and Oka H: Embolization of portal-systemic shunts in
cirrhotic patients with chronic recurrent hepatic encephalopathy.
Cardiovasc Intervent Radiol. 20:120–124. 1997.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Carrión JA, Bellot P, Colmenero J and
Garcia Pagan JC: Large spontaneous splenorenal shunt as a cause of
chronic hepatic encephalopathy. J Hepatol. 40(868)2004.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Arabi M, Almat'hami A, Qadri M and
Albenmousa A: Shunt-Preserving splenic vein embolization using a
vascular plug for treatment of hepatic encephalopathy. J Vasc
Interv Radiol. 26:1416–1419. 2015.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Uflacker R, Silva Ade O, d'Albuquerque LA,
Piske RL and Mourão GS: Chronic portosystemic encephalopathy:
Embolization of portosystemic shunts. Radiology. 165:721–725.
1987.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Qi X, Liu L, Bai M, Chen H, Wang J, Yang
Z, Han G and Fan D: Transjugular intrahepatic portosystemic shunt
in combination with or without variceal embolization for the
prevention of variceal rebleeding: A meta-analysis. J Gastroenterol
Hepatol. 29:688–696. 2014.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Pigott T: Advances in meta-analysis.
Springer Science & Business Media, 2012.
|
|
34
|
Flather MD, Farkouh ME, Pogue JM and Yusuf
S: Strengths and limitations of meta-analysis: Larger studies may
be more reliable. Control Clin Trials. 18:568–579; discussion
661-6. 1997.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Walker E, Hernandez AV and Kattan MW:
Meta-analysis: Its strengths and limitations. Cleve Clin J Med.
75:431–439. 2008.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Jagdish RK, Roy A, Kumar K, Premkumar M,
Sharma M, Rao PN, Reddy DN and Kulkarni AV: Pathophysiology and
management of liver cirrhosis: From portal hypertension to
acute-on-chronic liver failure. Front Med (Lausanne).
10(1060073)2023.PubMed/NCBI View Article : Google Scholar
|
